Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.53 - $2.0 $1,650 - $6,228
3,114 New
3,114 $6,000
Q2 2023

Aug 14, 2023

BUY
$0.57 - $1.38 $464 - $1,124
815 Added 440.54%
1,000 $1,000
Q1 2023

May 09, 2023

SELL
$0.68 - $1.11 $8,650 - $14,121
-12,722 Reduced 98.57%
185 $0
Q4 2022

Feb 10, 2023

SELL
$0.58 - $1.2 $12,193 - $25,228
-21,024 Reduced 61.96%
12,907 $9,000
Q3 2022

Nov 10, 2022

BUY
$0.66 - $2.32 $21,693 - $76,256
32,869 Added 3095.01%
33,931 $22,000
Q2 2022

Aug 15, 2022

SELL
$1.57 - $3.33 $12,908 - $27,379
-8,222 Reduced 88.56%
1,062 $2,000
Q1 2022

May 12, 2022

BUY
$2.76 - $4.64 $18,574 - $31,227
6,730 Added 263.51%
9,284 $30,000
Q4 2021

Feb 14, 2022

SELL
$4.09 - $7.16 $50,679 - $88,719
-12,391 Reduced 82.91%
2,554 $11,000
Q3 2021

Nov 15, 2021

BUY
$5.8 - $8.02 $86,072 - $119,016
14,840 Added 14133.33%
14,945 $89,000
Q2 2021

Aug 16, 2021

SELL
$6.87 - $9.16 $427,526 - $570,035
-62,231 Reduced 99.83%
105 $1,000
Q1 2021

May 17, 2021

BUY
$7.67 - $13.77 $445,887 - $800,505
58,134 Added 1383.48%
62,336 $536,000
Q4 2020

Feb 16, 2021

SELL
$12.07 - $17.95 $50,162 - $74,600
-4,156 Reduced 49.72%
4,202 $51,000
Q3 2020

Nov 16, 2020

BUY
$14.16 - $19.45 $86,545 - $118,878
6,112 Added 272.13%
8,358 $135,000
Q2 2020

Aug 13, 2020

BUY
$6.97 - $17.12 $15,654 - $38,451
2,246 New
2,246 $34,000
Q1 2020

May 15, 2020

SELL
$5.79 - $11.83 $31,074 - $63,491
-5,367 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$3.9 - $6.16 $20,931 - $33,060
5,367 New
5,367 $32,000
Q4 2018

Feb 14, 2019

SELL
$2.17 - $3.8 $3,252 - $5,696
-1,499 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$3.0 - $4.05 $2,628 - $3,547
-876 Reduced 36.88%
1,499 $6,000
Q2 2018

Aug 15, 2018

SELL
$3.15 - $4.7 $11,380 - $16,981
-3,613 Reduced 60.34%
2,375 $8,000
Q1 2018

May 15, 2018

BUY
$2.5 - $4.45 $11,865 - $21,119
4,746 Added 382.13%
5,988 $27,000
Q4 2017

Feb 09, 2018

BUY
$2.35 - $4.0 $2,918 - $4,968
1,242
1,242 $3,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $152M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.